Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Providence. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Providence at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy (PIT) in combination with pembrolizumab works to treat recurrent squamous cell cancer of the head and neck (HNSCC) with no distant metastases. It will also learn about the safety of ASP-1929 PIT in combination with pembrolizumab. Researchers will compare ASP-1929 PIT in combination with pembrolizumab to pembrolizumab alone or pembrolizumab plus chemotherapy (carboplatin or cisplatin, plus 5-fluorouracil or paclitaxel or
Sponsor: Rakuten Medical, Inc.
Check if you qualify for this head and neck cancer clinical trial in Providence, RI
If you're searching for head and neck cancer treatment options in Providence, RI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Providence research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.